Standout Papers

Oral Muvalaplin for Lowering of Lipoprotein(a) 2024 202635
  1. Oral Muvalaplin for Lowering of Lipoprotein(a) (2024)
    Stephen J. Nicholls, Wei Ni et al. JAMA

Immediate Impact

6 from Science/Nature 60 standout
Sub-graph 1 of 25

Citing Papers

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice
2024 Standout

Works of Wei Ni being referenced

The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
2023
Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response
2021

Author Peers

Author Last Decade Papers Cites
Wei Ni 424 177 79 130 46 907
M Dvořáková 362 168 42 129 62 910
A T Birmingham 461 250 74 117 47 1.1k
Bei Song 376 123 140 212 37 1.0k
Tatsunori Suzuki 423 136 74 72 28 955
Bruce Culver 318 116 52 153 28 977
Yiming Xu 499 184 39 120 39 1.1k
Qian Lu 371 147 105 55 48 982
Linan Zhang 420 145 43 59 44 932
Edmund Cheung So 314 132 44 102 72 981
Huijie Ma 288 129 64 146 68 1.0k

All Works

Loading papers...

Rankless by CCL
2026